Published December 2017
| public
Journal Article
Bone CLARITY reveals that anti-sclerostin antibody penetrates the lacunar canalicular system in mice under physiological loading conditions
Chicago
Abstract
Anti-sclerostin antibody (Scl-Ab) neutralizes sclerostin activity, a secreted protein from osteocytes, resulting in WNT mediated increases in bone formation and decreases in bone resorption; this dual effect on bone results in rapid increases in bone mass and strength.
Additional Information
© 2017 American Society for Bone and Mineral Research. First published: 28 December 2017. Disclosures: Alon Greenbaum, AMGEN, Grant/Research Support.Additional details
- Eprint ID
- 84174
- Resolver ID
- CaltechAUTHORS:20180108-144650592
- Amgen
- Created
-
2018-01-08Created from EPrint's datestamp field
- Updated
-
2021-11-15Created from EPrint's last_modified field